ASTH
Price
$25.70
Change
-$1.42 (-5.24%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.36B
36 days until earnings call
Intraday BUY SELL Signals
UHS
Price
$199.21
Change
-$2.60 (-1.29%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
12.61B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs UHS

Header iconASTH vs UHS Comparison
Open Charts ASTH vs UHSBanner chart's image
Astrana Health
Price$25.70
Change-$1.42 (-5.24%)
Volume$15.42K
Capitalization1.36B
Universal Health Services
Price$199.21
Change-$2.60 (-1.29%)
Volume$6.94K
Capitalization12.61B
ASTH vs UHS Comparison Chart in %
ASTH
Daily Signal:
Gain/Loss:
UHS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASTH vs. UHS commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and UHS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ASTH: $27.12 vs. UHS: $201.81)
Brand notoriety: ASTH and UHS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 118% vs. UHS: 122%
Market capitalization -- ASTH: $1.36B vs. UHS: $12.61B
ASTH [@Hospital/Nursing Management] is valued at $1.36B. UHS’s [@Hospital/Nursing Management] market capitalization is $12.61B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $109.38B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileUHS’s FA Score has 1 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • UHS’s FA Score: 1 green, 4 red.
According to our system of comparison, UHS is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 5 TA indicator(s) are bullish while UHS’s TA Score has 4 bullish TA indicator(s).

  • ASTH’s TA Score: 5 bullish, 4 bearish.
  • UHS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ASTH is a better buy in the short-term than UHS.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а -3.11% price change this week, while UHS (@Hospital/Nursing Management) price change was -8.99% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.21%. For the same industry, the average monthly price growth was -0.38%, and the average quarterly price growth was +6.74%.

Reported Earning Dates

ASTH is expected to report earnings on Feb 19, 2026.

UHS is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+0.21% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UHS($12.6B) has a higher market cap than ASTH($1.36B). ASTH has higher P/E ratio than UHS: ASTH (142.74) vs UHS (9.61). ASTH YTD gains are higher at: 9.311 vs. UHS (-7.435). UHS has higher annual earnings (EBITDA): 2.58B vs. ASTH (108M). ASTH has more cash in the bank: 463M vs. UHS (113M). ASTH has less debt than UHS: ASTH (1.09B) vs UHS (5.11B). UHS has higher revenues than ASTH: UHS (17B) vs ASTH (2.9B).
ASTHUHSASTH / UHS
Capitalization1.36B12.6B11%
EBITDA108M2.58B4%
Gain YTD9.311-7.435-125%
P/E Ratio142.749.611,486%
Revenue2.9B17B17%
Total Cash463M113M410%
Total Debt1.09B5.11B21%
FUNDAMENTALS RATINGS
ASTH vs UHS: Fundamental Ratings
ASTH
UHS
OUTLOOK RATING
1..100
2962
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
9152
SMR RATING
1..100
8946
PRICE GROWTH RATING
1..100
4554
P/E GROWTH RATING
1..100
279
SEASONALITY SCORE
1..100
4650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UHS's Valuation (19) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (86) in the null industry. This means that UHS’s stock grew significantly faster than ASTH’s over the last 12 months.

UHS's Profit vs Risk Rating (52) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (91) in the null industry. This means that UHS’s stock grew somewhat faster than ASTH’s over the last 12 months.

UHS's SMR Rating (46) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (89) in the null industry. This means that UHS’s stock grew somewhat faster than ASTH’s over the last 12 months.

ASTH's Price Growth Rating (45) in the null industry is in the same range as UHS (54) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to UHS’s over the last 12 months.

ASTH's P/E Growth Rating (2) in the null industry is significantly better than the same rating for UHS (79) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew significantly faster than UHS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHUHS
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 10 days ago
72%
Declines
ODDS (%)
Bearish Trend 15 days ago
75%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
UHS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TUR37.730.19
+0.51%
iShares MSCI Turkey ETF
SPTB30.490.02
+0.05%
State Street® SPDR® Portfolio Trs ETF
FB42.58-0.02
-0.05%
Proshares S&P 500 Dynamic Buffer ETF
IVOV105.50-0.07
-0.07%
Vanguard S&P Mid-Cap 400 Value ETF
RPHS10.27-0.03
-0.32%
Regents Park Hedged Market Strategy ETF

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-7.16%
ACHC - ASTH
48%
Loosely correlated
-5.14%
DCGO - ASTH
40%
Loosely correlated
-2.95%
PNTG - ASTH
31%
Poorly correlated
-0.38%
UHS - ASTH
31%
Poorly correlated
-2.01%
HCA - ASTH
31%
Poorly correlated
+1.05%
More

UHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, UHS has been closely correlated with HCA. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if UHS jumps, then HCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UHS
1D Price
Change %
UHS100%
-2.01%
HCA - UHS
78%
Closely correlated
+1.05%
THC - UHS
69%
Closely correlated
-0.21%
ENSG - UHS
58%
Loosely correlated
+0.65%
ACHC - UHS
55%
Loosely correlated
-5.14%
CON - UHS
52%
Loosely correlated
-1.60%
More